April 14, 2025 - 09:57
In a recent discussion, Thomas Quinn, the R&D Group Leader at a prominent biotechnology company, unveiled a groundbreaking technology aimed at improving lentiviral transduction efficiency. This new approach utilizes a macroporous sponge, which allows for significant advancements in the transduction process without relying on complex microfluidics-based systems.
Lentiviral transduction is a crucial technique in gene therapy, enabling the delivery of genetic material into target cells. Traditional methods often face challenges related to efficiency and scalability. However, the introduction of this innovative sponge technology promises to streamline the process, making it more accessible and effective for researchers.
Quinn emphasized that this method not only enhances the overall transduction rates but also simplifies the workflow, potentially leading to faster results in various applications, including therapeutic research and development. As the field of gene therapy continues to evolve, advancements like these are essential for overcoming existing limitations and pushing the boundaries of what is achievable in genetic engineering.
September 4, 2025 - 09:51
Janus Health Becomes Founding Member of Cipher Collective’s AI Health Technology NetworkJanus Health, a provider of revenue cycle technology, has officially joined the Cipher Collective’s AI Health Technology Network. This initiative aims to streamline the adoption of artificial...
September 3, 2025 - 21:56
The Rise of Agentic AI: Navigating the New FrontierIn the rapidly evolving landscape of artificial intelligence, the concept of agentic AI is emerging as a pivotal area of focus. Many organizations are grappling with questions surrounding the...
September 3, 2025 - 12:22
Exploring CHAT's Strategic Approach to AI Technology Investments for Sustainable GrowthDiscover how CHAT delivers long-term capital growth through tactical investments in global AI technology equities. In an era where artificial intelligence is rapidly transforming industries, CHAT`s...
September 2, 2025 - 19:36
Dr. Sunil Chandran Returns to Lead Technological Innovations at AmyrisAmyris, Inc. is excited to welcome back Dr. Sunil Chandran as its Chief Technology Officer. His return comes at a pivotal moment when the company is poised to enhance its capabilities in innovative...